Dr. Hui Wang manages Mass General Brigham’s strategic research alliances with several industry partners and is responsible for managing and licensing select intellectual property portfolios, including technologies arising from the Center for Regenerative Medicine and Center for Computational and Integrative Biology at Massachusetts General Hospital. Prior to joining Mass General Brigham, she was a licensing associate at the University of Virginia licensing and ventures group. She earned her PhD in chemistry from the State University of New York at Stony Brook, where she studied islet amyloid formation and its association with type 2 diabetes. She was also an intern at SUNY Stony Brook’s technology transfer office.